Issue Date: February 8, 2016
How China Is Improving The Drug Approval Process
When Zhejiang Pharmaceutical Association organized a conference on Chinese drug approval reforms in Hangzhou, China, participation was strong. About 500 people, mostly from drug firms operating in the province, attended the one-day event in December.
“Our objective is to have a response rate faster than foreign regulatory agencies such as the U.S. FDA,” Jiaxi Xu, director of the Center for Drug Evaluation at the China Food & Drug Administration . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society